TABLE 3.
Sleep behaviors | Total (N) | Cases (N) | Basic model* | Fully adjusted model† | PAR% (95% CI) |
HR (95% CI)a | HR (95% CI)a | ||||
Early chronotype | 206,425 (62.77) | 31,686 (15.35) | 0.95 (0.94–0.97) | 1.00 (0.98–1.01) | −1.42 (−2.04 to −0.80) |
Sleep 7–8 h/day | 227,871 (69.29) | 33,049 (14.50) | 0.88 (0.87–0.90) | 0.94 (0.92–0.95) | 4.17 (3.62–4.72) |
Never/rarely insomnia | 83,012 (25.24) | 11,510 (13.87) | 0.92 (0.90–0.94) | 0.94 (0.92–0.96) | 8.39 (7.02–9.74) |
No self-reported snoring | 207,777 (63.18) | 29,664 (14.28) | 0.93 (0.91–0.95) | 0.99 (0.97–1.01) | 5.67 (5.04–6.30) |
Rarely daytime sleepiness | 321,158 (97.66) | 48,208 (15.01) | 0.77 (0.73–0.81) | 0.83 (0.79–0.87) | 0.82 (0.68–0.96) |
All five factors (overall)b | 24,548 (7.46) | 3,147 (12.82) | 0.89 (0.86–0.92) | 0.96 (0.93–1.00) | 15.30 (12.58–17.93) |
*Basic model: adjusted for age, sex, and ethnicity. aCompared with all other participants not in this low-risk group. bAll low-risk factors were included simultaneously in the same model, and participants without all five low-risk behaviors were set as the reference †Fully adjusted model: additionally adjusted for Townsend Deprivation Index, education, BMI, smoking status, alcohol consumption, physical activity, healthy diet, family history of diseases (cancer and CCVD), and medication (sleep-related drugs and aspirin/ibuprofen).